Data / Form D filings / ARRAY BIOPHARMA INC
ARRAY BIOPHARMA INC: Form D filings
ARRAY BIOPHARMA INC, a biotechnology company in Boulder, CO, filed 2 Form D notices with the SEC in 2009. The latest, on August 12, 2009, reports an offering of no set size with nothing sold yet to 2 investors.
Find out what ARRAY BIOPHARMA INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3200 WALNUT STREET, Boulder, CO, 80301
- Phone
- (303) 381-6600
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $25,000,001 - $100,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1100412
The full lists. Form D filings in Colorado: 1,787 rows, $89.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 12, 2009 | Amendment | Indefinite | $0 | Indefinite | 2 | May 15, 2009 | sec.gov |
| May 29, 2009 | New notice | Indefinite | $0 | Indefinite | 2 | May 15, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Marvin H. Caruthers | Director | |
| John L. Zabriskie | Director | |
| Douglas E. Williams | Director | |
| Gil J. Van Lunsen | Director | |
| Robert E. Conway | Executive Officer, Director | |
| Kyle A. Lefkoff | Director | |
| David Snitnam | Executive Officer, Director | |
| R. Michael Carruthers | Executive Officer | |
| Francis J. Bullock | Director | |
| Kevin Koch | Executive Officer, Director | |
| John R. Moore | Executive Officer |
Other biotechnology companies in Colorado that filed recently
- HealthVest Fund V LLC offering · Nov 5, 2026
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
Every Form D from the week of Aug 10, 2009 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ARRAY BIOPHARMA INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.